These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 15879693)
21. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options. Kemp SF BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167 [TBL] [Abstract][Full Text] [Related]
22. The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus. Cheetham TD; Taylor A; Holly JM; Clayton K; Cwyfan-Hughes S; Dunger DB J Endocrinol; 1994 Aug; 142(2):367-74. PubMed ID: 7523562 [TBL] [Abstract][Full Text] [Related]
23. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Thrailkill KM Diabetes Technol Ther; 2000; 2(1):69-80. PubMed ID: 11467325 [TBL] [Abstract][Full Text] [Related]
25. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism. Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572 [TBL] [Abstract][Full Text] [Related]
26. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes. Clemmons DR; Sleevi M; Allan G; Sommer A J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090 [TBL] [Abstract][Full Text] [Related]
27. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288 [TBL] [Abstract][Full Text] [Related]
28. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Bereket A; Lang CH; Wilson TA Horm Metab Res; 1999; 31(2-3):172-81. PubMed ID: 10226799 [TBL] [Abstract][Full Text] [Related]
29. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Acerini CL; Patton CM; Savage MO; Kernell A; Westphal O; Dunger DB Lancet; 1997 Oct; 350(9086):1199-204. PubMed ID: 9652560 [TBL] [Abstract][Full Text] [Related]
30. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258 [TBL] [Abstract][Full Text] [Related]
31. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex. Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087 [TBL] [Abstract][Full Text] [Related]
32. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy]. Peczyńska J; Urban M; Głowińska B; Urban B Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196 [TBL] [Abstract][Full Text] [Related]
33. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes? Dunger DB; Acerini CL Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221 [TBL] [Abstract][Full Text] [Related]
34. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose. Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252 [TBL] [Abstract][Full Text] [Related]
35. Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile. Quattrin T; Thrailkill K; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Giltinan D; Gesundheit N; Martha P Diabetes Care; 1997 Mar; 20(3):374-80. PubMed ID: 9051390 [TBL] [Abstract][Full Text] [Related]